CD86 and acute myeloid leukemia: We observed CD86 expression in 61 of 333 (18.32% with an MFI ratio > 1.5; Fig. 1A) and PD-L1 expression in 21 of 377 (5.57% with an MFI ratio > 1.5; Fig. 1A) primary AML samples.